Natalia Gonzalez Caldito
Neurology · Honolulu, HINPI 1013414978
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,564 of the $5,133 with a category attached, or 88.9%. It is spread thinly across 27 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,450, 2.7 times the $893 reported in 2022.
Across 105 payments — averaging $48.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$776
- Novartis$623
- Argenx US, Inc.$483
- AbbVie$414
- UCB, Inc.$386
- Amgen$367
- plus $2K from 21 others
Across 11 payments — averaging $2923.26 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Argenx US, Inc.$31K
- Vertex$1K
What the payments were for
- Food & beverage$4,56489%
- Education$56911%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 11 | $776 |
| Novartis | 9 | $623 |
| Argenx US, Inc. | 7 | $483 |
| AbbVie(2 entities) | 16 | $414 |
| UCB, Inc. | 6 | $386 |
| Amgen | 11 | $367 |
| Biogen | 4 | $244 |
| TG Therapeutics, Inc. | 5 | $232 |
| Sanofi | 2 | $224 |
| Genentech USA, Inc. | 4 | $200 |
| Genentech, Inc. | 2 | $178 |
| CSL Behring | 2 | $145 |
| EMD Serono, Inc. | 2 | $136 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $118 |
| Merz Pharmaceuticals, LLC | 2 | $118 |
| SK Life Science, Inc. | 3 | $93 |
| Ipsen Biopharmaceuticals, Inc | 2 | $65 |
| Jazz Pharmaceuticals Inc. | 3 | $63 |
| Bristol Myers Squibb | 2 | $57 |
| Cycle Pharmaceuticals Inc | 2 | $39 |
| Janssen Scientific Affairs, LLC | 1 | $32 |
| Sarepta Therapeutics, Inc. | 1 | $32 |
| Acadia Pharmaceuticals Inc | 1 | $26 |
| Lundbeck LLC | 1 | $24 |
| Tanabe Pharma America, Inc. | 1 | $19 |
| Averitas Pharma Inc. | 1 | $19 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,133 in reported general payments places this provider in the 70th percentile of 54 neurology providers in Hawaii.
Other neurology in Honolulu
- Leo MaherHonolulu$382K
- Leah RidgeHonolulu$47K
- Melvin YeeHonolulu$32K
- Kevin KimataHonolulu$24K
- Terry ShimamotoHonolulu$24K
- Michael RussoHonolulu$20K
- Kore LiowHonolulu$15K
- Fay GaoHonolulu$13K
- Sarah GranerHonolulu$10K
- Jeffrey LiuHonolulu$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.